While protection against mild illness waned over time, the mRNA vaccines from Moderna and Pfizer-BioNTech provided a robust shield against the worst outcomes.
After authorization by the Food and Drug Administration and sign-off by the Centers for Disease Control and Prevention, eligible patients can get any of the three available booster doses, regardless of which shot they got first.